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Brief Cognitive Behavioral Therapy for College Students With ADHD:
A Case Series Report
Laura D. Eddy, Will H.Canu, Joshua J. Broman-Fulks, and Kurt D. Michael, 
Attention-deficit/hyperactivity disorder (ADHD) is often diagnosed in childhood but persists into adulthood in many cases. This 
disorder, which is defined by the core symptoms of IA and HI, is also associated with impairment in academic settings, interpersonal 
relationships, and behavioral risk taking. While ADHD is most often treated with medication (e.g., stimulants), brief psychosocial 
treatments have also been shown to produce improvement in adults with ADHD, although these have not been adequately tested in 
college-age populations. The current study tested a brief, eight-session cognitive-behavioral protocol in a case-series design with four 
college students with ADHD. Participants completed measures tapping ADHD symptoms, anxiety, depression, and general impairment 
in academic, social, and employment domains. The findings indicate that the protocol may be useful as a short-term treatment option for 









e ofTENTION-DEFICIT/HYPERACTIVITY disorder (ADHD) is a 
sychological disorder characterized by three core
ptoms: inattention (IA), hyperactivity, and impulsivity
; American Psychiatric Association, 2013). While previ-
y considered a childhood-limited disorder, research has
consistently lag behind in education and occupatio
attainment when compared with what is expected gi
their intellectual abilities (Biederman et al., 2008). Ad
with ADHD also report more impairment in import
critical day-to-day tasks, such as driving (e.g., higher rat
arrests, speeding tickets, accidents) as compared with thoseconclusively showed that symptoms persist into adulthood
in the majority of cases (Biederman et al., 2010; Faraone &
Biederman, 2005; Fischer, Barkley, Smallish, & Fletcher,
2005; Kessler et al., 2005). Although hyperactivity tends to
decline across time (Biederman, Mick, & Faraone, 2000;
Mick, Faraone, & Biederman, 2004), the other core
symptoms of ADHD can still cause adults considerable
difficulties in time management, attention, planning,
judgment, and coping, which are all associated with
dysfunction in several life domains (e.g., education, work,
relationships, and emotional well-being; Mannuzza, Klein,
Bessler, Malloy, & LaPadula, 1998; Safren, Sprich, Cooper--
Vince, Knouse, & Lerner, 2010). Research has also shown
that those with ADHD are at elevated risk for other
psychiatric disorders, particularly anxiety, mood, and
substance use disorders, complicating assessment and
treatment (Kessler et al., 2006; Sobanski et al., 2007).
Moreover, not only do adults with ADHD attain less
education and professional training as compared with
nondiagnosed peers (Sobanski et al., 2007), they also
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indicated that a childhood diagnosis of ADHD is associated
with risky sexual behavior in adulthood (e.g., more sexual
partners, sexual encounters with strangers, unplanned
pregnancies; Flory, Molina, Pelham, Gnagy, & Smith,
2006). The breadth of difficulties encountered by adults
with ADHD underscores the importance of developing
effective means of intervention with this population.
Interventions for Adult ADHD
The neurobiological nature of ADHD would seem
to lend itself to pharmacological treatment. Indeed, a
substantial body of research establishes that medication
(e.g., psychostimulants) reduces IA and hyperactivity in
adults (Mészáros et al., 2009), while the response rate is
noticeably lower than that in children (Wilens, Biederman,
& Spencer, 1998; Wilens, Spencer, & Biederman, 2002) and
negative side effects such as nausea, lowered appetite, and
insomnia may give adult clients further pause when
considering this intervention option. Moreover, adults
with ADHD who present to outpatient psychiatric clinics
typically do not show a high response rate to widely
practiced psychodynamic or other “traditional” psychother-
apeutic methods (Ramsay, 2010). Finally, while the alterna-
tive “ADHD coaching” offers psychoeducation and
behavioral scaffolding, scant evidence documents its effica-
cy, and given that many coaches lack sufficient training in
other forms of assessment and intervention this form of
intervention might only be indicated as an adjunctive
therapy (Goldstein, 2005).
Fortunately, evidence exists for efficacy of several other
psychosocial treatments for ADHD in adults. Variants of
cognitive-behavioral therapy (CBT) have been noted to be
particularly fitting for the typical dysfunctions of that
population. Safren, Otto, and colleagues (2005), for
instance, reason that the core neurological deficits of the
disorder often result in (a) a history of failure, under-
achievement, and relationship problems; and (b) an
overarching lack of compensatory strategies such as
organization, planning skills, and management of distract-
ibility, which on a daily basis reinforce negative self- and
ability-related cognitions. Such models may explain why
many affected adults who are treated pharmacologically
continue to experience impaired functioning, in that
medication treats the core symptoms of ADHD but does
not address dysfunction stemming from the lifelong
struggle with disorder.
While not extensive, existent data from randomized
clinical trials has documented the efficacy of (a) CBT plus
pharmacotherapy as compared with pharmacotherapy
alone (Safren, Otto, et al., 2005), (b) cognitive remedi-
ation as compared with wait-list (Stevenson, Whitmont,
Bornholt, Livesy, & Stevenson, 2002), and (c) CBT or a
similar metacognitive therapy1 versus other active treat-
ments (Safren, Sprich, Mimiaga, et al., 2010; Solanto et al.,
2010). In addition, an open-label feasibility trial of
mindfulness meditation, which can be construed as a
metacognition intervention, also facilitated decreases in
ADHD and other symptoms (Zylowska et al., 2008).
Further, several case studies of CBT for adult ADHD have
contributed to the literature by providing detailed
information about treating individuals of different ages,
backgrounds, and deficits (Mitchell, Nelson-Gray, &
Anastopoulos, 2008; Ramsay & Rostain, 2005; Rosenfield,
Ramsay, & Rostain, 2008). Thus, it seems reasonable to
conclude that cognitive and behavioral therapies, broadly
defined, facilitate improvement in adults with ADHD.
A review of this literature indicates, however, that most
samples had a mean age over 40, with a notable dearth of
typical college-age adult participants (ages 18–23 years). This
is a meaningful gap, given that research suggests that college
students with ADHD demonstrate strikingly lower academic
achievement levels, higher relative rates of emotional
problems and social concerns, and higher rates of substance1 The metacognitive protocol of Solanto and colleagues (2010) is
based on cognitive-behavioral theory and is fairly similar to the
protocol designed by Safren, Perlman, Sprich, and Otto (2005) with
respect to content.use (Blase et al., 2009). As Fleming and McMahon (2012)
highlight in their review of the developmental context for
college students with ADHD, success in undergraduate
education may be particularly challenging for affected
individuals due to (a) increased demands on self-regulation
and management, organization, and planning combined
with (b) a simultaneous loss of structure and support from
parents and educators, and (c) a neurological system with
not-yet-fully developed capacities. Moreover, even when
pharmacological interventions produce reductions in core
ADHDsymptoms among college students, these students still
fall substantially below their peers without ADHD in terms of
executive functioning and continued psychosocial impair-
ment (DuPaul et al., 2012). Further, most of the published
studies on CBT for adult ADHD utilize 10 or more sessions
(Knouse & Safren, 2010; see exception in Stevenson et al.,
2002), which may pose adherence hurdles, particularly for
typical college students with ADHD. In sum, this body of
work suggests that special focus on psychosocial treatment
for college students with ADHD is warranted.
Current Study
Given thatmost controlled trials of CBT have included 10
or more treatment sessions and samples have been largely
composed of middle-aged adults, more detailed research on
the efficacy of briefer protocols in younger populations is
warranted. An eight-session CBT protocol could more
readily be completed in one semester at a college or
university, making it amenable to use by campus counseling
centers, which typically cap services to cope with increased
client loads (Stone & McMichael, 1996). Furthermore,
some evidence suggests that the number of completed
therapy sessions is not predictive of outcome in CBT (Kraft,
Puschner & Kordy, 2006), suggesting that an abbreviated
protocol may be efficacious while also being more cost-
effective. The current study examines the use of an
abbreviated CBT protocol, adapted from Safren, Perlman,
Sprich, and Otto (2005), to gather more detailed qualitative
and quantitative information on its efficacy for treating
college students with ADHD. The abbreviated protocol
consists of 8 sessions, representing a 33% reduction from the
original protocol, which consisted of 12 sessions (Safren,
Perlman, et al., 2005). It was hypothesized that completion of
the intervention would facilitate functional gains and
diminish symptoms of ADHD, and that participants would
express satisfaction with the treatment method and content.
Method
Participants
Four participants were recruited via staff referrals and
flyers from those seeking services at a psychology
department training clinic and other on-campus service
providers at a public university. All participants were
between 19 and 25 years old and attending the university
2 The same rater who performed treatment integrity checks (see
below) also designated CGI ratings as an informal reliability check.
Overall, agreement with the original rating was adequate; all instances
of differences minimal in magnitude (i.e., 1 point) and in a more
lenient direction (i.e., indicating lower impairment than noted
herein).or a community college in a rural town in the Southeastern
United States. All had a documented diagnosis of ADHD-C
(50%) or ADHD-IA (50%; see details in Procedures,
below). Comorbid anxiety or depressionwerenot exclusion
criteria, and only one participant (25%) met criteria for a
comorbid disorder. Participants currently taking medica-
tion for ADHDwere asked not to deviate from their current
regimenduring treatment.No compensation was provided,
though participants were permitted to keep the materials
they used (e.g., therapy workbook). Further details
regarding participant characteristics appear in the case--
specific sections below.
Measures
In addition to demographic questions that were admin-
istered in a semistructured interview and follow-up question-
naire, the following specific measures were administered.
Adult Interview
The Adult Interview (Barkley & Murphy, 2006) is a
semistructured interview covering DSM-IV-TR (American
Psychiatric Association, 2000) criteria for ADHD and
commonly comorbid disorders. This measure has been
shown to be sensitive to the presence of ADHD in adults
(Barkley, Fischer, Edelbrock, & Smallish, 1990), and was
included as a clinician evaluation tool for that condition.
Additional questions clarified nicotine and alcohol con-
sumption patterns.
Current Symptoms Scale (CSS)
The CSS (Barkley & Murphy, 2006) is an 18-item
self-report that uses a 4-point scale (0 = not at all, 3 = very
often) to assess current DSM-IV-TR (American Psychiatric
Association, 2000) symptoms of ADHD. The CSS has
shown satisfactory psychometric properties, with a
Cronbach’s alpha of .80 for IA and .73 for HI scales
(Fedele, Hartung, Canu, & Wilkowski, 2010).
Conners Adult ADHD Rating Scale–Self-Report: Long Version
(CAARS)
This measure (Conners et al., 1999) adheres to
DSM-IV-TR ADHD criteria (American Psychiatric
Association, 2000) and indexes the past 6 months’ behavior.
Four subscales were used: DSM-IV IA and HI symptoms (9
items each), the ADHD index (12 items, e.g., “I can’t get
things done unless there’s an absolute deadline”), and
problems with self-concept (6 items; e.g., “I act okay on the
outside, but on the inside I’munsure of myself”). The latter
was of particular interest, and figured in the inclusion of the
CAARS to supplement the CSS (see above). Responses are
on a 4-point scale (0 = not at all, never; 3 = very much, very
frequently). The CAARS is psychometrically strong, with
coefficient alphas (α) from .86 to .92, test–retest r = .89,
and expected associations with other measures (Erhardt,
Epstein, Conners, Parker, & Sitarenios, 1999).Weiss Functional Impairment Rating Scale, Self-Report (WFIRS-S)
TheWFIRS-S (Weiss et al., 2007) is designed to measure
functional impairment associated with ADHD in seven
domains: family (8 items), work (11 items), school
(11 items), life skills (12 items), self-concept (5 items),
social (9 items), and risky behavior (14 items). Responses
are scaled and indicate if problems occurnever (0), sometimes
(1), often (2), or very often (3). Impairment is considered to
be present in any domain with two items = 2 or one item =
3. Mean item scores are reported for each domain in which
the threshold for impairment was met. Psychometric
properties of theWFIRS are good, with internal consistency
coefficients above .80 for each domain and for themeasure
as a whole (Weiss et al., 2007).
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
The SCID-I (Spitzer, Williams, Gibbon, & First, 1992)
assesses the occurrence of symptoms of disorders from
Axis I of the DSM-IV-TR (past month and lifetime), and
was included to evaluate for possible conditions comorbid
to (or subsuming) ADHD. Independent studies have
reported interrater reliability for the SCID-I to be generally
satisfactory across diagnoses (kappa .61–.83, M = .71;
Lobbestael, Leurgans, & Arntz, 2010). The SCID-I screener
was employed, with follow-up administration of indicated
modules only.
Beck Depression Inventory-II (BDI) and Anxiety Inventory (BAI)
The BDI (Beck, Steer, & Brown, 1996) and BAI (Beck &
Steer, 1990) are commonly used self-reports (21 items
apiece) with excellent psychometric properties that tap
symptoms of depression and anxiety. Responses range
from 0 to 3 (0 = not at all present/not at all upsetting, 3 =
strongly present/severely upsetting) and are summed to deter-
mine an individual’s total score. Scores are classified as
minimal (BDI 0–13, BAI 0–7), mild (BDI 14–19, BAI 8–15),
moderate (BDI 20–28, BAI 16–25), or severe (BDI 29+,
BAI 26+).
Clinical Global Impression Scale (CGI)
The CGI (Guy, 1976) is a commonly used expert-rater
measure of treatment effects. The severity of illness and
global improvement items, used herein as per procedures of
Safren, Otto, et al. (2005), are rated on a 7-point scale. For
severity of illness, lower scores indicate better psychological
functioning, and lower global improvement scores indicate
an improvement in symptoms and functioning. TheCGI was
completed jointly by the first and second authors.2
Outcome Questionnaire 30.2 (OQ-30)
The OQ-30 (Lambert et al., 1996) is a 30-item
self-report that is often used and is designed to be
sensitive to change across even brief intervention periods.
Dimensions of functioning measured include social role,
interpersonal, and subjective discomfort. The OQ-30
has demonstrated high internal consistency (α = .93)
and satisfactory concurrent validity with other measures
(e.g., r = .7 with Symptom Checklist-90-R, r = .60 with
BDI; Lambert et al., 1996).
Treatment Satisfaction Survey
This questionnaire, adapted from Canu and Bearman
(2011), consists of five items assessing participant satis-
faction and impressions of the treatment. Example items
include “How satisfied were you with this intervention?”
and “How useful are the techniques you’ve learned
so far?” Responses are scaled (1 = not at all, 5 = very),
with a mean item score reported. Internal reliability
has been found to be good (α = .81; Canu & Bearman,
2011). Qualitative data regarding treatment impressions
were tapped with four additional questions; examples
include “What aspects (if any) of the treatment led toTwo to three weeks
Seven weeks (Sessions 2–7)
Screening
Session 1
(Pretreatment measures administered 
immediately prior)
Session 8
(Posttreatment measures administered  
immediately afterward)
Figure 1. Timeline and assessment measures used throughout treatme
Outcome Questionnaire; CSS = Current Symptoms Scale; CAARS = C
Impairment Rating Scale, Self-Report; BDI = Beck Depression Invento
Functioning; CGI = Clinical Global Impression Scale.improvement of your symptoms or adjustment?” and




During individual screening interviews (see below),
participants provided informed consent. While limited
treatment-tracking data was collected at each of the
sessions, the primary evaluation points were at pre- and
posttreatment (i.e., before Session 1, after Session 8).
Further details follow (also see Figure 1).
Screening Session
Potential participants were instructed to bring corrobo-
rating ADHD assessment reports to the screening. The SCID
was administered to all participants and, in the absence of
adequate prior psychological assessment documentation, all
othermeasures described above (save theOQ-30.2, CGI, and
satisfaction survey) were administered to determine eligibil-
ity. A current GAF score was assigned, based on available
information and consensus between the first and second
authors (master’s trainee and licensed clinical psychologist,With adequate assessment report: SCID, OQ-
30, CSS
Other participants: SCID, Adult Interview, 
CSS, CAARS, WFIRS-S, BDI, BAI, GAF, 
OQ-30
CAARS, CSS, WFIRS-S, BDI, BAI, CGI, 
OQ-30
CSS, CAARS, WFIRS-S, BDI, BAI, OQ-30, 
CGI, GAF, Treatment Satisfaction Survey
nt.Note: SCID: Structured Clinical Interview for DSM-IV; OQ-30 =
onners Adult ADHD Rating Scale; WFIRS-S = Weiss Functional
ry; BAI = Beck Anxiety Inventory; GAF = Global Assessment of
Table 1
Original Protocol Sessions and Descriptions
Session Title Content
Module One
1 Psychoeducation and Introduction to
Organization and Planning Skills
Provide psychoeducation about ADHD, set client goals and provide
overview of treatment, and introduce notebook and calendar systems
2 Involvement of Family Member Not included
3 Organization of Multiple Tasks Teach skills pertaining to management of multiple tasks and
prioritizing tasks
4 Problem Solving and Managing
Overwhelming Tasks
Teach skills pertaining to problem solving and work on breaking
down problem into small, manageable parts
5 Organizing Papers Not included
Module Two
6 Gauging Attention Span and
Distractibility Delay
Teach skills pertaining to gauging attention span, go over how to
break down tasks into parts corresponding to attention span,
and teach the distractibility delay technique
7 Modifying the Environment Teach techniques to help manage distractibility in work environment,
and engage in problem solving with client to address common
distractions
Module Three
8 Introduction to a Cognitive Model of ADHD Present CBT model for ADHD, teach skills pertaining to the
identification of automatic thoughts, utilize thought records to
identify negative thoughts and thinking errors, and discuss how
to label thinking errors
9 Adaptive Thinking Review thought records and discuss the formulation of a
rational response to negative automatic thoughts




11 Application of Skills to Procrastination Use a “pros and cons” exercise to identify the attractive aspects
and negative consequences of procrastination, and go over
how to use problem-solving skills and adaptive thinking techniques
to manage procrastination
12 Relapse Prevention Review strategies and skills learned over the course of treatment,
address how to maintain gains, and discuss how to deal with possible
problems in the future
Note. Sessions in boldface type were retained in full or presented in abbreviated or combined format in the brief protocol.respectively). All participants met full DSM-IV-TR ADHD
diagnostic criteria at screening.
Pretreatment Assessment
Prior to the start of the first session, each participant
completed the CAARS, CSS, WFIRS-S, BDI, and BAI, and
was assessed with the CGI.
Posttreatment Assessment
The posttreatment outcome assessment immediately
followed the last session, and included the CSS, CAARS,
CGI, WFIRS-S, BDI, BAI, and the treatment satisfaction
survey. At the end of the assessment, participants were
assigned a GAF score based on all available clinical data.
Participants were also invited to give their subjectiveimpressions of the usefulness of the treatment and its
impact on their daily functioning.Additional Qualitative Assessment
Therapy sessions were videotaped and reviewed by the
first author to enhance treatment delivery and for
additional qualitative data regarding treatment response.
An independent evaluator examined 25% of the treat-
ment sessions for integrity of treatment delivery. Specific
sessions observed across participants were as follows:
Participant 1, Sessions 1 and 5; Participant 2, Sessions 2
and 6; Participant 3, Sessions 3 and 7; Participant 4,
Sessions 4 and 8. The evaluator found that the adminis-
tration of the protocol in all sessions was faithful to the
design.
Treatment Protocol
The treatment consisted of eight, hour-long weekly
sessions adapted fromMastering Your Adult ADHD (Safren,
Perlman, et al., 2005; see Table 1). The original protocol
organizes 12 sessions into 4 modules. Sessions were
eliminated based on low apparent relevancy to college
students to abbreviate treatment. Two sessions were
eliminated from the first module, entitled Psychoeduca-
tion, Organization, and Planning, leaving: (a) Psychoe-
ducation and Introduction to Organization and Planning
Skills, (b) Organization of Multiple Tasks, and (c) Problem
Solving and Managing Overwhelming Tasks. The second
module, on reducing distractibility, retained all of
the original protocol’s content, with two sessions entitled
(a)GaugingAttention Span and (b)DistractibilityDelay and
Modifying the Environment. Two of the three original
sessions from the adaptive thinkingmodule were retained to
present the cognitive model and teach adaptive thinking—
that is, (a) Introduction to a CognitiveModel of ADHD, and
(b)Adaptive Thinking. The fourthmodule, Additional Skills
(i.e., Application of Skills to Procrastination and Relapse
Prevention), was covered in one session. In addition, a
graduate student assistant conducted one brief (i.e., 5- to
10-minute) support phone call to each participant per week,
during which guidance and assistance with treatment
techniques and homework were provided, as necessary,
and a reminder given regarding the subsequent scheduled
session time.This is keepingwith the structureof the original
intervention of Safren, Otto, et al. (2005). Participants were
given theMastering Your Adult ADHD (Safren, Perlman, et al.,
2005) client workbook for their personal use during
treatment.
Results
Case Presentation: Participant 1
Anna3 was a 19-year-old Caucasian female and a
second-semester college freshman. She presented with
time management and organization concerns, and
reported that although she was highly motivated, she
still found it difficult to study effectively, which often led
to personal distress. Anna noted that her parents
described her as “difficult” in childhood, and she had
problems sitting still, interrupting others, and sustaining
her attention across settings. She reported getting in
trouble at school, and described herself as excitable. In
third grade, a psychiatrist diagnosed her with ADHD-C
and prescribed a medication regimen. She has continued
her pharmacotherapy (currently 54 mg Concerta and
50 mg Zoloft/day). Anna reported making good grades
(A’s and B’s) before college, though her grades declined
substantially as an undergraduate. Anna described3 Pseudonyms are utilized throughout this document to protect the
confidentiality of participants.finding the expectations of college coursework difficult
and anxiety provoking (e.g., regarding future academic
prospects). In addition to current challenges in school,
Anna reported significant difficulties relating to a
roommate resulting in Anna moving to a single room,
as well as impulsive behavior that upset other friends.
Anna reported no significant substance use.
Progress in Treatment
At her screening session, Anna had elevations on the
CAARS problems with self-concept, DSM-IV IA and HI
symptoms, and ADHD index scales (see Table 2 for
detailed screening, pre-, and posttreatment scores), and
she endorsed three symptoms of IA and seven of HI on
the CSS. On the WFIRS, Anna reported impairment in
work (two items = 2), life skills (one item = 3), social
(three items = 2, one item = 3), and risk (two items = 2,
one item = 3) domains. Anna reported moderate levels of
depressive and anxious symptoms (BDI = 23, BAI = 26),
and the clinical interview indicated social phobia and
generalized anxiety disorder comorbidities. Anna’s
OQ-30 score was at the 86.4th percentile of psychiatric
impairment, compared with a normative sample. Anna
was assigned a GAF score of 54. Anna described her goals
for treatment as “learning to work more effectively” and
“to manage impulsivity.”
At study initiation (i.e., pretreatment),4 Anna had high
scores on DSM-IV IA symptoms, DSM-IV HI symptoms,
and ADHD index scales on the CAARS. On the WFIRS,
Anna reported impairment in work (two items = 2), social
(two items = 2), and risk (two items = 3) domains. On the
CSS, she endorsed two IA and seven HI symptoms. Her
BDI score (8) signaled less depressive symptomatology
but her BAI score (16) was relatively consistent as
compared with screening. Anna’s OQ-30 report equated
to the 75.8th percentile. Overall, she was assigned a
CGI-severity score of 5 at baseline.
At posttreatment, Anna’s IA symptoms as measured by
the CAARS DSM-IV IA symptoms scale had reduced
slightly (T = 63, from 65 at initiation) into the normal
range, but this change did not exceed the range of
possible measurement error. Furthermore, Anna’s ADHD
index score increased from 68 to 75 on pre- to
posttreatment measurements. While the latter was an
improvement from her screening score of 82, it remained
in the clinical range. Anna reported no change on CSS
symptoms, as compared with pretreatment. Anna exhib-
ited negligible depression and minimal anxiety (BDI = 6,
BAI = 11), representing an improvement from both her
screening session scores and her scores at study initiation.
On the WFIRS, Anna no longer reported impairment in4 Reminder: Study initiation was subsequent to screening; there-
fore, scores vary between the two.
Table 2
Screening, Pretreatment, and Posttreatment Scores
Participant 1 Participant 2 Participant 3 Participant 4
Measure Screen Pre-Tx Post-Tx Screen Pre-Tx Post-Tx Screen Pre-Tx Post-Tx Screen Pre-Tx Post-Tx
DSM-IV IA 69 65 63 – 90 90 61 77 39 77 77 77
DSM-IV HI 84 84 84 – 64 59 51 56 36 49 54 46
Problems with self-concept 69 57 59 – 68 63 38 49 36 53 49 44
ADHD index 82 68 75 68 71 65 45 50 36 55 55 48
CSS-IA 3 2 2 8 8 9 6 3 0 9 4 4
CSS-HI 7 7 7 7 5 2 4 3 0 4 0 0
WFIRS-Family 0.38 0.25 0.13 _ 0.86 0.25 0.25 0.13 0 0.43 0.5 0.25
WFIRS-Work 0.72 0.73 1.09 _ 0.91 0.45 0.64 0 0 0.27 0.18 0.18
WFIRS-School 0.27 0.27 0.73 _ 1.91 1.73 0.45 0.64 0 1 1.09 1.18
WFIRS-Life Skills 0.58 0.5 0.33 _ 0.92 0.25 0.83 0.58 0 0.67 0.75 0.58
WFIRS-Self-Concept 1.2 1 1 _ 2 1 1.2 0.4 0 0.6 0.2 0.4
WFIRS-Social 1.2 1 0 _ 0.5 0.11 0 0.11 0 0.11 0 0.11
WFIRS-Risk 0.85 0.5 1 _ 1.2 0.14 0.29 0.36 0 1 0.79 0.71
BDI 23 8 6 _ 13 7 7 1 0 5 2 5
BAI 26 16 11 _ 3 1 5 3 5 21 7 6
OQ-30 45 39 18 59 53 30 19 4 5 35 32 22
CGI-severity – 5 4 – 5 4 – 2 2 – 4 3
GAF 54 – 71 51 – 74 61 – 85 58 – 71
Note. Scores for the CAARS subscales (DSM-IV IA; DSM-IV HI; ADHD index, problems with self-concept) are T scores. CSS IA and CSS HI
scores are positive symptom counts. WFIRS domain scores are composite scores, with higher scores indicating more impairment. BDI and BAI
scores are symptom counts of depressive and anxiety symptoms, respectively. Scores for the OQ-30 are composite scores, reflect degree of
impairment, and are highly sensitive to change over time and treatment. IA = inattention; HI = hyperactivity and impulsivity; CSS = Current
Symptoms Scale; WFIRS = Weiss Functional Impairment Rating Scale; BDI = Beck Depression Inventory; BAI = Beck Anxiety Inventory;
OQ-30 = Outcome Questionnaire; CGI = Clinical Global Impression Scale; GAF = Global Assessment of Functioning.the social domain, but continued to do so in work (two
items = 2, one item = 3) and risk (four items = 2)
domains. She also noted impairment in school (three
items = 2), which was not present at pretreatment.
Anna’s score on the OQ-30 was improved at posttreat-
ment (15.9th percentile). At study initiation, Anna
reported that she sometimes felt irritated and nervous,
and felt stressed at work, school, or other daily activities.
In contrast, at posttreatment Anna reported that she
rarely or never felt irritated or nervous, and she rarely felt
stressed at work, school, or other daily activities. Anna was
assigned a GAF score of 71, reflecting her posttreatment
ability to manage her symptoms and to function
adaptively, particularly in her academic work. She was
also assigned a CGI severity score of 4 and a CGI
improvement score of 2.
On the treatment satisfaction survey, Anna endorsed
high satisfaction (item M = 4). Anna reported that she
believed the adaptive thinking module and cognitive
strategies were integral to her improvement. She noted
that using thought records led to a “healthier perspective”
and a reduction in her stress. Additionally, by applying
strategies to manage distractibility and breaking tasks
down into subtasks, Anna reported being able to workmore efficiently, and her confidence in her academic
ability increased as a result.Case Presentation: Participant 2
Zeb was a 25-year-old Caucasian male student in his
second semester at community college after a yearlong
academic break. Zeb’s complaints were procrastination,
poor time management and organizational skills, and
severe inattention. Zeb was first diagnosed with ADHD IA
at age 13 following academic difficulties, although his
documentation included parent reports of prior symptoms.
Zeb reported always having difficulty paying attention in his
classes, remembering assignments, and studying, and his
procrastination and forgetfulness impacted his daily life
(e.g., chores, errands). He made average grades through
high school, but experienced frustration and amotivation
that he partly attributed his performance to. Zeb’s
inattention and amotivation continued in college; he
often dropped classes and had to withdraw from his prior
university due to poor grades. While he used prescribed
Ritalin through high school, he ceased taking medication
regularly in college and had recently fully discontinued
due to negative side effects. Zeb reported consuming
alcohol and marijuana regularly since age 17; his current
reported consumption of both substances was considerable
(i.e., alcohol on weekends at 10+ drinks/day, marijuana
1+ times/day). Despite experiencing substantial impair-
ment due to symptoms of ADHDand substance use, he had
not previously sought mental health treatment.
Progress Over Treatment
Zeb provided a recent evaluation report from the local
psychology training clinic as evidence of his diagnosis; as
such, the abbreviated battery was administered at
screening. At that time, Zeb endorsed eight symptoms
of IA and seven symptoms of HI on the CSS. His reports
yielded a score at the 97.1st percentile on the OQ-30, and
his GAF score was 51. Zeb’s goals were to better manage
procrastination and work more effectively.
At pretreatment, Zeb had elevated DSM-IV IA symp-
tom and ADHD index scores on the CAARS. On the CSS,
he endorsed eight symptoms of IA, and also five HI
symptoms. Zeb reported significant impairment in work
(two items = 2), school (two items = 2, five items = 3), life
skills (two items = 2, one item = 3), self-concept (one item =
3, three items = 2), and risk (two items = 2)WFIRS domains.
Zeb reported minimal anxiety (BAI = 3) and borderline
depressive symptoms (BDI = 13). He scored at the 93.3th
percentile on the OQ-30. Zeb was assigned a pretreatment
CGI severity score of 5. Overall, these scores are consistent
with the data collected at screening.
At posttreatment, Zeb continued to report high
CAARS DSM-IV IA and ADHD index scores; on the CSS,
he reported nine symptoms of IA and two of HI. However,
Zeb reported improvement on the WFIRS, with impair-
ment noted only in school (four items = 3, two items = 2).
Zeb reported minimal anxiety (BAI = 1) and depression
(BDI = 7), consistent with previous reports, and his
OQ-30 report was improved (50th percentile). The most
notable changes on the latter measure were in self--
confidence (e.g., “I feel that something is wrong with my
mind,” I feel hopeless about the future,” and “I feel that
something bad is going to happen). Zeb was assigned a
post treatment CGI severity score of 4 and an improve-
ment score of 2. His GAF score of 74 reflects that although
he still reported some significant ADHD symptoms, he
was less impaired and had begun to implement strategies
that positively impacted his day-to-day life.
On the treatment satisfaction survey, Zeb indicated
high satisfaction (item M = 4.1). He noted that the
structured nature of the treatment and the individual
attention he received were important to his improvement,
and that the stimulus control strategies were particularly
useful. This is of note given initial skepticism due to his
prior failed attempts to control distractions. He also
indicated optimism regarding simultaneous use of all his
new skills to make further gains.Case Presentation: Participant 3
Mark was a 21-year-old Caucasian male junior, pre-
senting with complaints about time management, pro-
crastination, forgetfulness, poorly managing large tasks,
and impulsivity. Although performing satisfactorily in
school, he noted having trouble meeting his personal
goals. Mark was first diagnosed with ADHD-C by a family
physician in first grade after exhibiting difficulty with
emotional lability, sitting still in class, following directions,
inattention, and other maladaptive behaviors (e.g., exces-
sive talking). He was prescribed Ritalin to address these
symptoms. Mark endorsed math as the only subject that he
has long-standing difficulty in, and despite spending lots of
time studying for math tests he typically gets very anxious,
forgets facts, and performs poorly. Mark consulted a
psychiatrist regarding this and social anxiety during high
school, and was prescribed Zoloft. He had a current
prescription for Strattera (100 mg/day), which Mark
perceived to address both his ADHD and anxiety. Mark
revealed that he occasionally also takes immediate-release
Adderall, when he wants to “really focus” on work. Mark
described himself as “rebellious” and “emotional” as a
child, but that these tendencies faded and he sees himself
currently as “even-tempered.” Mark reported that he does
not use any illicit drugs or tobacco, but does consume
alcohol on weekends (five to six drinks/drinking episode).
Progress Over Treatment
Mark completed the full screening battery, and
endorsed slightly elevated IA (T = 61) on the CAARS,
and six IA and four HI symptoms on the CSS. On
the WFIRS, Mark indicated ADHD-related impairment
in work (one item = 3, two items = 2), school (one item =
3), life skills (four items = 2), and self-concept (three
items = 2). He reported minimal depression and anxiety.
Mark scored at the 18.4th percentile on the OQ-30. He
did not meet criteria for any comorbid disorder (per
SCID-I). Mark was assigned a GAF score of 61. He
described his goals for treatment as improving his
efficiency and time management, to keep better track of
personal items, and to reduce forgetfulness.
At pretreatment, Mark endorsed elevated DSM-IV IA
symptoms on the CAARS, but reported only three
symptoms of IA and of HI on the CSS. On the WFIRS,
Mark reported significant impairment in school (one
item = 3, two items = 2) and life skills (one item = 3)
domains, and negligible levels of depressive (BDI = 1)
and anxious symptoms (BAI = 3). His OQ-30 result was
unimpaired (0.3rd percentile). At this juncture, Mark was
assigned a CGI severity score of 2. These pretreatment
scores were noticeably lower than those at screening, with
the exception of the CAARS DSM-IV IA score. It may be
noteworthy that Mark’s pretreatment assessment took
place directly after spring break when he reported very
low academic stress.
At posttreatment, Mark reported no elevations on any
CAARS subscale, symptoms of IA or HI on the CSS, or
significant impairment on the WFIRS. He reported no
depressive symptoms (BDI = 0) and minimal anxiety
(BAI = 5). On the OQ-30, Mark’s report again was in an
unimpaired range (0.5th percentile). He was assigned a
final CGI severity score of 2 and an improvement score of
3. Mark was assigned a GAF score of 85, reflecting high
functioning and few ADHD symptoms.
On the treatment satisfaction survey, Mark indicated
very high satisfaction (item M = 4.6). He also reported
that the treatment helped him become more aware of
how his symptoms interfered with his adjustment, and
how to manage the symptoms. Mark identified the task
list, prioritizing system, and the cognitive techniques
(e.g., identifying thought errors, using adaptive thinking)
as most crucial to his perceived treatment success.
Interestingly, despite Mark’s low BAI score, he described
persistent maladaptive thoughts concerning compe-
tence, accompanied by stress and anxiety. By using the
adaptive thinking techniques, Mark felt more in control
of this worry. Mark also noted that breaking tasks down
helped him to work more productively.
Case Presentation: Participant 4
David was a 22-year-old Caucasian male presenting
with complaints about time management, procrastina-
tion, and inefficiency in his schoolwork. Despite being a
college senior with an impressive academic record, he
noted that he turned in most assignments late and had
never turned in a paper on time. David was diagnosed with
ADHD IA at 14 years of age by a neurologist, after the
mounting complexity of academic tasks and expectations
in class and at home began to cause him difficulty. He was
prescribed 25 mg of Adderall/day, which he continued
until his junior year in college, desisting at that point due
to negative side effects. Unfortunately, David reported
this exacerbated ADHD-related impairment, and he
could have made better grades if on medication. David
indicated that he had significant past HI symptoms as well,
such as difficulty sitting still and playing quietly, across
settings. Despite having ADHD, his academic perfor-
mance has been excellent, perhaps due to very superior
cognitive ability (per standardized intellectual test results,
in prior assessment). David indicated minimal substance
use, including some alcohol on weekends and marijuana
two- to three-times per month.
Progress Over Treatment
David completed the CAARS, CSS, BDI, BAI, WFIRS,
and the OQ-30 at his screening session, along with the
Adult Interview and SCID-1. He had elevations on theCAARS DSM-IV inattentive and ADHD symptoms total
scales. On the WFIRS, David reported significant impair-
ment in school (two items = 2, one item = 3), life skills
(three items = 2), and risk (five items = 2) domains. On
the CSS, David reported nine symptoms of IA and four of
HI. He reported few depressive symptoms, but moderate
anxiety. On the OQ-30, David scored at the 65.5th
percentile. Overall, he was assigned a GAF of 58. His
treatment goals were to improve time management,
control over distractibility, and to more successfully attain
other personal goals.
At pretreatment, David again had elevated CAARS
DSM-IV IA and ADHD total symptoms scores, and
significant impairment in WFIRS school (two items = 2,
one item = 3), life skills (two items = 2), and risk (two
items = 2) domains. On the OQ-30, David’s score at
pretreatment was at the 57.9th percentile, and he
reported minimal depression (BDI = 2). While these
data were consistent with his screening, David reported
only four IA and no HI symptoms on the CSS, and low
anxiety (BAI = 7), all decreases. Overall, he was assigned a
pretreatment CGI severity score of 4.
While the treatment was designed to occur over eight
sessions, David could only attend seven, one of which was
extended to cover missed material. At posttreatment,
David reported elevated DSM-IV IA symptoms on the
CAARS, but his total symptoms score was in the normal
range. On the CSS, he again reported four IA and no
HI symptoms. His scores on the WFIRS indicated that he
still experienced impairment, but only in school (two
items = 3) and life skills (one item = 3). At posttreatment,
David was assigned a CGI severity score of 3, CGI
improvement score of 3, and GAF score of 71, reflecting
that his reported symptoms were similar to study initiation
but he was implementing some new skills and felt more in
control of his symptoms. However, his verbal reports of
improvement were not reflected in WFIRS responses.
David reported minimal posttreatment depression
(BDI = 5) and anxiety (BAI = 6). On the OQ-30, David’s
score at posttreatment was substantially lower, at the
27.4th percentile. This reflected gains in self-confidence
regarding schoolwork, even though his workload was
higher at the end of treatment (i.e., at end of the
semester). David reported that he felt stressed at work,
school, and other daily activities only sometimes, in contrast
with frequently at study initiation. For instance, in response
to both “I am not working/studying as well as I used to”
and “I feel that I am not doing as well at work/school or in
other daily activities,”David responded rarely, a noticeable
improvement from pretreatment ratings of frequently and
sometimes, respectively.
On the treatment satisfaction survey, David endorsed
high treatment satisfaction (item M = 4.2) and described
it as helpful and interesting, noting the weekly schedule,
prioritization and task management, and distractibility
delay elements as keys to his perceived improvement.
Both David and the therapist reflected that his perceived
struggle with time management may have been the
result of a tendency to set unrealistic deadlines for
himself (i.e., finishing an entire lab report in one night).
Learning to set more realistic goals and to break tasks into
smaller parts allowed him to better accomplish the goals
he set for himself.
Overall Summary of Results
With regard to reduction of core ADHD symptomatology
(see Table 2), participants reported a mean T score
reduction of 8.25 on the CAARS DSM-IV HI, 5 on the
CAARS ADHD index, and 5.25 on the self-concept scales.
CAARS DSM-IV IA was dramatically reduced in one
participant (38 points), but showed little-to-no change in
others (zero or 2-point reductions). Participants endorsed
.5 fewer IA symptoms on the CSS and 1.5 fewer HI
symptoms. On the WFIRS, participants reported impair-
ment in amean of 3.25 domains (out of 7) at pretreatment,
and a mean of 1.5 domains at posttreatment. On the
OQ-30, a mean score reduction of 16.25 points was
observed. Participants formally reported a high level of
satisfaction with the treatment, and verbally indicated that
the treatment increased their insight into how ADHD
impacts their lives. Overwhelmingly, participants indicated
that the treatment was valuable because it improved their
ability to manage dysphoria, and the cognitive techniques
were specifically noted as effective at reducing anxiety
related to maladaptive schemas arising from their life
experiences with ADHD.
Discussion
The principal aim of this study was to gather evidence
regarding the possible utility of an abbreviated, eight-session
version of the Safren, Perlman, et al., (2005) Mastering Your
Adult ADHD protocol in typically aged, full-time college
students. Considering these four clients as a group, there was
a trend toward positive change, but the degree and exact
nature of improvement varied. Posttreatment ratings on the
OQ-30 and WFIRS consistently indicated improved adjust-
ment, with three out of four participants evidencing a
decrease (M = .31 points on a 4-point scale) across WFIRS
domains rated as impaired at pretreatment, and similar
robust results noted in OQ-30 scores (i.e., three participants
demonstrating reliable change, per Jacobson & Truax,
1991). However, improvement of core ADHD symptoms,
tapped by the CSS and CAARS, was generally modest.
In this study, there were two major procedural
differences that might have contributed to the limited
gains, as compared with Safren, Otto, et al. (2005). First,
the Mastering Your Adult ADHD (Safren, Perlman, et al.,
2005) protocol was abbreviated by four sessions herein.While perhaps better for treatment accessibility and
compliance among undergraduates, this obviously limited
the breadth and repetition of material covered, especially
regarding procrastination management and adaptive
thinking. These two topics were generally noted as novel
and helpful by participants, and additional emphasis
might have led to better outcomes. In addition, relapse
prevention was covered in half of a session in the current
intervention. This might have reduced participants’
confidence in their ability to effectively apply skills in
the future, potentially coloring their posttreatment. It
may be that adhering to the content of Mastering Your
Adult ADHD, perhaps in an intervention spanning two
college semesters, would be a way to conveniently and
effectively deliver CBT to college students with ADHD,
and seems a fruitful idea for future study. A second
noteworthy procedural difference is in clinician experi-
ence. In the study conducted by Safren, Otto, et al.
(2005), the therapists were licensed psychologists who
had considerable experience delivering CBT, and who
had assisted in developing the protocol used in this study.
In contrast, the clinician herein was a second-year
graduate student with relatively limited experience and
prior familiarity with this particular protocol, which may
have reduced its effectiveness. While treatment fidelity
checks did suggest that the elements of the protocol were
faithfully delivered, it could be that unmeasured factors
such as overall experience as a therapist or specific level of
comfort with delivering this treatment played a role in the
observed results.
In addition, participants in Safren, Otto, et al. (2005)
had a mean age of 45 years, whereas herein the mean was
approximately 22 years. Differences among these age
groups in prototypical patterns of activity and related
stress may need to be taken into consideration when
evaluating treatment response. Workload and related
stress may be more highly variable in college populations
as compared with older adults, which may have an effect
on reports of symptoms and adjustment. In addition,
there might be differences in commitment level and
motivation to change between college-aged adults and
older counterparts. For instance, it has been noted that
age is positively associated with adherence in and
abstinence after treatment for alcohol dependence
(Oslin, Pettinati, & Volpicelli, 2002). Perhaps older
adult clients with ADHD have higher motivation for
change than their younger peers, as well. Furthermore,
three participants listed their top pretreatment goal as
learning to work effectively. When reduction of core
ADHD symptoms was mentioned, it was clearly secondary
to functional improvement goals. Hence, it is possible that
participant expectancies may have influenced self-re-
ported outcomes, with a bias toward improvement in
functional adjustment (vs. ADHD symptoms). Finally,
while treatment outcomes were less clearly positive than
those reported by Safren, Otto, et al. (2005), discrepan-
cies in case severity seem likely between the current sample
and that enrolled in the latter. Participants across both
studies met DSM-IV-TR criteria for ADHD diagnosis at
enrollment, yet those in the current study fell in
mild-to-moderate impairment ranges (e.g., GAF = 61 to
51, WFIRS mean domain scores ≤ 1), whereas those in
Safren, Otto, et al.’s (2005) CBT treatment group were
marked by severe impairment (e.g., CGI M = 5.0) despite
stable pharmacotherapy at pretreatment. In effect, the
relatively mild nature of impairment in the current
sample may have created a de facto ceiling effect in
terms of observed positive gain, relative to that in Safren,
Otto et al. (2005).
Interestingly, it appears that those who chose to forgo
medication at least partly (i.e., Participants 2, 3, and 4)
showed more improvement in functional adjustment, per
WFIRS ratings. This is encouraging when considering
efficacy of CBT and like therapies for young adults with
ADHD, in that it suggests some positive effect is possible
even without adjunctive pharmacotherapy, and further
that such treatments may be appropriate stand-alone
interventions for college students with relatively mild
symptoms. This particular pattern of results, however,
remains somewhat confusing, as the participants included
in a prior study of adults with ADHD using an extended
version of the current protocol were all stabilized on an
ADHD medication regimen and tended to benefit
incrementally with CBT (Safren, Otto, et al., 2005).
Another CBT approach, Solanto et al.’s metacognitive
therapy, however, has tended not to produce differential
treatment effects based on medication status (Solanto,
Marks, Mitchell, Wasserstein, & Kofman, 2008; Solanto
et al., 2010). In light of such an ambiguous history, it
seems that the best interpretation is that consistent
medication use should be neither an inclusion nor an
exclusion criteria for psychosocial intervention for ADHD
in adults, as the potential for benefit seems to exist for
medicated and unmedicated individuals, alike.
Overall, two out of four participants displayed a
meaningful pre- to posttreatment decrease in symptoms
on either the BDI or BAI (i.e., Anna, BAI: 16 to 11; Zeb,
BDI: 13 to 7), and this even with screening- to pretreatment
decreases that might have to do with treatment expectancy
(e.g., Anna, BAI: 26 to 11) that were observed in all
participants who completed the screening session. While it
is heartening that the treatment seemed to reduce
comorbid symptomatology in some, the overall degree of
change attributable to active treatment on these measures
was quitemodest in comparisonwith the results observedby
Safren, Otto, et al. (2005) and in comparison with that
captured by theOQ-30 andWFIRS.However, given that the
reported pretreatment mood and anxiety symptoms weregenerally low (see Table 2), there may be a floor effect in
terms of possible improvement and, as such, it might be
appropriate to interpret this lesser response with some
caution. While these quantitative results regarding anxiety
and depression are somewhat equivocal, it is of note that all
participants noted via written feedback that the cognitive--
behavioral strategies emphasized in their treatment helped
reduce stress and anxiety, and also increased self-confi-
dence. This may not been reflected very well in BAI scores,
with its focus on somatic symptoms. Future studies might
benefit from using ameasure of anxiety that captures more
of its cognitive aspects (e.g., Penn State Worry Question-
naire; Meyer, Miller, Metzger, & Borkovec, 1990), or
one that focuses specifically on academic-related anxiety
(e.g., Achievement Anxiety Test; Alpert & Haber, 1960).Treatment Implications
The abbreviated protocol used in this study may hold
promise for use in college counseling centers, which often
choose short-term, cost-effective treatment models. Given
the pattern of results, it might serve well as an ADHD-
specific adjunct to individual or group CBT for college
students with comorbid ADHD and mood and/or anxiety
disorders. In addition, the current, structured approach
may be particularly suited for college students reporting
mild to moderate levels of ADHD-related impairment and
symptomology. In such cases, this treatment may serve as a
“jump-start” by rapidly helping to improve adaptation and
increasing motivation for change, which might be facilitat-
ed by longer-term psychotherapy or medical intervention.
Alternately, this treatment might be useful for college
students recently diagnosed with ADHD, in that offering a
nonpharmacological option as a primary or secondary
intervention has been shown to increase perceptions of
treatment acceptability, which could bolster motivation to
begin and follow-through (Krain, Kendall, & Power, 2005;
Wilson & Jennings, 1996).
Given an academic term’s escalating nature, clinicians
are advised to begin treatment early in the semester so that
clients may acquire foundational skills while the academic
workload is lighter. In addition, clinicians should expect that
students’ affective symptoms might naturally increase when
the workload is heaviest. Extra emphasis on using prioriti-
zation, task management, and planning strategies at these
times to balance daily responsibilities with academic work
might moderate such setbacks. In addition, several partic-
ipants herein had concerns regarding procrastination,
which was not formally addressed until the seventh session.
Feedback from the participants confirmed they wished it
had been addressed earlier in treatment. Procrastination
may be more problematic for college students than the
older adults included in Safren, Otto, et al. (2005), and
students may benefit from addressing this issue earlier and
monitoring procrastination through a longer period of the
treatment (e.g., estimating how much time spent procras-
tinating in past week). This could be a valuable metric of
progress over the course of treatment that is especially
relevant to this population. Qualitative, posttreatment data
suggests effectiveness at addressing participants’ key areas of
concern, such as time management and procrastination,
and participants reported improved ability to work effec-
tively using the treatments’ strategies as well as a high sense
of satisfaction with the intervention.Limitations and Future Directions
Considering the case series design, the lack of a control
group and the small sample size stand out as the two most
serious limitations. Generalizability of the results is thus
inherently limited, and the possibility that improvements
may be due to chance alone cannot be ruled out.
Therefore, the evaluation of this protocol in larger,
controlled trials is a key direction for future research.
Furthermore, given the relatively mild impairment in the
current sample it would be particularly important to
examine CBT’s effectiveness for individuals with more
severe ADHD-related symptoms and impairment. Howev-
er, it should be noted that both males and females as well
as 4-year and community college students participated,
and gains were observed across the group. A multi-
ple-baseline strategy might also be employed in future
small-sample treatment studies to allow for controlled
comparison of cases.5 Furthermore, much of the data
reported herein was self-reported, which has its limita-
tions, at least for ADHD symptom reports, in terms of
reliability when compared with parent report (see Sibley
et al., 2012). Collecting additional treatment outcome
data from roommates, close friends, romantic partners, or
parents of participants, or utilizing additional measures of
posttreatment adjustment (e.g., grade point average at
end of term, substance use changes) and pretreatment
data regarding readiness to change would be ideal in
future studies.
Another direction for future efforts is to optimize the
role of “support person” for college student clients.
Participants reported that it was better to simply receive
reminders about sessions than have discussion of home-
work and other treatment issues. Many simply did not
answer calls from the support assistant. Employing a
roommate or friend as a support person, or setting up an
automatic text messaging equivalent, might merit consid-
eration. In addition, future studies might employ group
or self-directed online treatment formats.5 Unfortunately, unexpected delays in recruitment for the current
study precluded a multiple baseline design.References
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